GSK to buy U.S.-listed cancer drug developer Nuvalent for $10.6B in its largest deal in more than decade, marking strategic shift under new CEO as British company steps up focus on oncology - AOS for Lemmy.World - A generic Lemmy server for everyone to use.

10

GSK to buy U.S.-listed cancer drug developer Nuvalent for $10.6B in its largest deal in more than decade, marking strategic shift under new CEO as British company steps up focus on oncology

8d 2h ago by lemmy.world/u/Innerworld in Mergers_Acquisitions from www.reuters.com